This introductory course will provide you with a grounding knowledge of regulatory affairs in Europe. After three days you will have a clear understanding of the EU regulatory structure and have a solid grasp of the submission process and the standards required by the regulators.
Through interactive exercises you will gain a practical insight into the European legal & regulatory environment; the registration procedures that are available, and the structure of the registration dossier. The course will adopt a practical approach that will enable you to apply what you have learned to your daily work.
Sumaiya Patel is a director of a regulatory consultancy with over 11 years’ experience in both pre and post-approvals for generic, CRO and big pharma organisations. Sumaiya has experience in regulatory implementation and training, focusing on CMC, clinical development, strategy and manufacturing. She has extensive experience in writing Module 3 of CTD, Module 2 of the CTD and also Quality Expert statements to support dossiers and Type II Quality variations. She has a track record of providing regulatory inputs related to CMC aspects during the development product lifecycle.
July 2017 Reviews:
“The practical case studies which made you consider all aspects of the course was great.”
Regulatory Affairs Officer, Eurogenetics
“The fact that we got to share our experiences as well as learn from practical cases was excellent.”
Senior Manager Regulatory Affairs, Fresenius Kabi
“There was a lot of information given and a good trainer with a wealth of knowledge.”
Quality Officer QC PS, Sanquin Plasma Products BV
April 2017 Reviews:
“I enjoyed the practical examples, case studies and discussions the most. I took the course to learn about Regulatory Affair EU Specifics and found the course definitely met my objectives.”
Simone Machutta, Regulatory Affairs Specialist, Bayer AG
“I found the instructor was excellent when taking this course. I chose the course because of the specific topic it deals with and to gain an insight into the possibilities of what will happen to Regulatory Affairs following Brexit, as this is a big concern for Regulatory Affairs people.”
Consultant, Marla Piercy
Interaction between the trainer and the participants was useful and the case studies were very informative.